In This Story Pfizer (PFE+1.26% ) announced Monday that it is ending development of its daily weight-loss pill following a liver injury to a patient participating in a trial. The patient, who was … [+1736 chars]...
Read moreOmar Havana / Contributor / Getty Images
We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best pharma … [+6271 chars]...
Read moreAstraZeneca (NASDAQ:AZN – Get Free Report) will likely be issuing its Q1 2025 quarterly earnings data before the market opens on Tuesday, April 29th. Analysts expect AstraZeneca to post earnings of $… [+3703 chars]...
Read moreThe markets have succumbed to the tariff-fueled selling pressure, and there is nowhere to hide. President Trumps tariff plan is intensifying the trade war. The Dow Jones Industrial is spiraling by ov… [+139 chars]...
Read moreAstraZeneca AZN-Q may face a fine of up to $8-million in China over suspected unpaid taxes related to the import of its breast cancer drug Enhertu, the drug maker said on Tuesday, as it works to revi… [+146 chars]...
Read more